RIGL Q2 2017 Earnings — Rigel Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

RIGLRigel Pharmaceuticals, Inc.

$517M

Q2 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$12M

Operating Income

-$19M

Net Income

-$19M

EPS (Diluted)

$-1.56

QoQ Revenue Growth

-100.0%

Cash Flow

Operating Cash Flow

-$19M

Free Cash Flow

-$19M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$85M

Total Liabilities

$16M

Stockholders' Equity

$70M

Cash & Equivalents

$33M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$9M	-100.0%
Gross Profit	-$12M	-$9M	-29.9%
Operating Income	-$19M	-$14M	-41.7%
Net Income	-$19M	-$14M	-41.5%